What are examples of active infections that would warrant withholding intravenous (IV) iron therapy in a patient with chronic kidney disease (CKD) stage 2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Active Infections Warranting Withholding IV Iron in CKD Stage 2

Intravenous iron should be withheld during any active infection in patients with CKD stage 2, as these patients were systematically excluded from randomized controlled trials and iron is essential for nearly all infectious microorganisms. 1

Rationale for Withholding IV Iron During Active Infection

The KDIGO conference participants explicitly recommend withholding IV iron during active infections because:

  • Iron is essential for nearly all infectious microorganisms, particularly gram-negative and other siderophilic bacteria that utilize non-transferrin-bound iron for pathogen reproduction 1
  • Patients with active infections were systematically excluded from all currently available randomized controlled trials of IV iron therapy, leaving no safety data for this population 1
  • Iron may inhibit the host's innate immune response to bacterial infection while simultaneously promoting bacterial growth 2

Examples of Active Infections Requiring IV Iron Withholding

While the guidelines do not provide an exhaustive list, the following categories of active infections warrant withholding IV iron therapy:

Bacterial Infections

  • Gram-negative bacterial infections (particularly concerning as these pathogens are specifically siderophilic and utilize non-transferrin-bound iron) 1
  • Staphylococcus aureus and Staphylococcus epidermidis infections (common nosocomial pathogens that have developed iron acquisition mechanisms) 1
  • Any documented bacteremia or sepsis 1, 3
  • Skin and soft tissue infections with systemic signs 1, 2

Other Active Infections

  • Pneumonia with fever or systemic inflammatory response 3, 2
  • Urinary tract infections with systemic symptoms 3, 2
  • Any infection requiring antibiotic therapy 1, 4

Clinical Approach to Infection Assessment

Before administering IV iron, assess for:

  • Fever, chills, or other systemic signs of infection 1, 2
  • Elevated inflammatory markers (C-reactive protein elevation may indicate active infection rather than chronic inflammation) 5
  • Recent antibiotic use or ongoing antibiotic therapy 4
  • Abrupt increase in ferritin with sudden drop in transferrin saturation (suggests acute inflammatory process/infection rather than iron overload) 5

When to Resume IV Iron After Infection Resolution

  • Wait until the active infection has clinically resolved before resuming IV iron therapy 1, 2, 4
  • In hemodialysis patients, ferritin levels decreased from high to normal within 4 months after resolving inflammatory states, suggesting this timeframe for ferritin normalization post-infection 6
  • The absence of an urgent clinical need for iron should guide conservative timing of resumption 3

Important Caveats

The infection-iron relationship is bidirectional but primarily unidirectional in causation:

  • Infection causes elevated ferritin levels (as an acute-phase reactant) 5, 6
  • However, administering iron during active infection may worsen the infection by providing essential nutrients to pathogens 1, 2
  • This is distinct from the observation that elevated ferritin from chronic inflammation does not necessarily cause infections 6

Oral iron may be considered as an alternative during or shortly after infection resolution, particularly in non-dialysis CKD patients, as it poses less risk of creating non-transferrin-bound iron that pathogens can utilize 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical practice guidelines on iron therapy: A critical evaluation.

Hemodialysis international. International Symposium on Home Hemodialysis, 2017

Guideline

Ferritin Levels in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Time Frame for Ferritin to Return to Normal After Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.